Art Unit 1629

Group 1620Biomedicinal Chemistry

Active examiners
33
Average office actions per grant
1.84

Grant ratio

Art Unit 1629
53.0%
Group 1620
61.2%

Active examiners

Kevin E. Weddington 73.8% 1.71 October 2026
Raymond J Henley Iii 80.1% 1.19 October 2026
Michael J Schmitt 49.1% 1.82 October 2026
Rei-Tsang Shiao 82.2% 1.30 September 2026
William Lee 47.4% 2.32 October 2026
Ibrahim D Bori 38.1% 2.28 October 2026
Chris E Simmons 38.3% 2.75 October 2026
Savitha Rao 61.0% 1.62 September 2026
Sara E. Townsley 23.2% 2.24 October 2026
Yong Chu 73.4% 1.71 September 2026
Anthony Seitz 33.6% 2.01 October 2026
Heather Dahlin 18.1% 1.71 October 2026
Eric Tran 35.8% 1.75 October 2026
Bong-Sook Baek 31.5% 2.05 October 2026
Irina Neagu 11.3% 1.99 September 2026
Alexander K Showalter 19.0% 1.58 September 2026
W. Justin Youngblood 13.0% 1.33 October 2026
San-Ming Hui 74.7% 2.07 September 2026
Gigi Huang 31.7% 2.61 October 2026
Zohreh Fay 44.8% 2.30 October 2026
Paul Randall Gauger 7.1% 1.00 September 2026
Christopher Evan Redwood 0.0% N/A October 2026
Liliana Cerullo 0.0% 1.00 July 2026
Andrew P Lee 0.0% 3.05 October 2026
Angela Brown-Pettigrew 20.0% 2.17 September 2026
Manahil Mirghani Ali Abdalhameed 0.0% 1.77 October 2026
Alan D Diamond 0.0% 1.87 September 2026
Ali Saeed 0.0% 3.25 October 2026
Deborah D. Carr 100.0% 1.37 September 2026
Gillian A Hutter 0.0% 1.88 October 2026
Jarrod Stanley 0.0% N/A September 2026
Liyuan Mou 0.0% 1.73 October 2026
Luisalberto Gonzalez 100.0% 2.00 October 2026

Examiner distribution

Median grant ratio
37.0%
Middle 50% of grant ratios
20.1%–58.0%
Median office actions / grant
1.82
Middle 50% of office actions / grant
1.62–2.24

Active examiners with at least 20 applications.

Other associated examiners

Examiners without recent activity.

Based on available public USPTO records; may be incomplete.

Job History

These are temporarily preserved for your convenience, but expire quickly for your security. We never save substantive inputs, pasted text, and/or uploaded files.

Jobs will appear here.